Davis Jerel, Director, 10% Owner at Turnstone Biologics Corp. (TSBX), bought 2,753,864 shares at $12.00 ($2.7M) on 2023-07-25, disclosed to the SEC on 2023-07-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,528,864 | $0 | 0.0% |
| 2 | $12.00 | 5,939 | $71K | 2.6% |
| 3 | $12.00 | 6,575 | $79K | 2.9% |
| 4 | $12.00 | 15,028 | $180K | 6.7% |
| 5 | $12.00 | 197,458 | $2.4M | 87.8% |
| Total | $0.98 avg | 2,753,864 |
| $2.7M |
| 100% |
| Filing → |
| RPTX | SELL | 2022-12-13 | $4.0M | — | Filing → |
| RPTX | SELL | 2022-06-07 | $15.3M | — | Filing → |
| KDNY | SELL | 2022-01-05 | $16.0M | — | Filing → |